Affordable Care Act: Implications in Female Pelvic Medicine and Reconstructive Surgery
- 199 Downloads
The Patient Protection and Affordable Care Act (PPACA) of 2010 marks an important milestone in redefining how healthcare will be practiced in the United States for decades to come. This review article will outline the basic concepts associated with the PPACA, including value-based purchasing, pay for performance, accountable care organizations, bundled payments, and patient-centered medical homes, and will discuss how each of these components of the PPACA will impact the subspecialty of Female Pelvic Medicine and Reconstructive Surgery (FPMRS).
KeywordsValue-Based Purchasing Accountable Care Organizations Bundled Payments Patient-Centered Medical Homes Quality Measure Guideline Clinical Data Registry
Compliance with Ethics Guidelines
Conflict of Interest
Dr. Anne M. Suskind has received a grant from NIDDK (T32).
Dr. J. Quentin Clemens has served as a consultant for Medtronic and Afferent Pharmaceuticals. Dr. Clemens owns stock in Merck. Dr. Clemens received multiple grants from NIDDK (U01 DK082345-05; R01 DK083927; R24 DK094583-01; U01 DK099932).
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.•Organization for Economic Cooperation and Development. OECD Health Data 2012; how does the United States Compare. 2012. This is a good and contemporary descripton of how the United States compares in GDP and per capita health expenditures to other developed countries. Google Scholar
- 2.Institute of Medicine. To err is human: building a safer health care system. Washington, DC: National Academy Press; 1999.Google Scholar
- 11.••American Urological Association. Guidelines. 2013. http://www.auanet.org/education/clinical-practice-guidelines.cfm. Accessed June 11, 2013 2013. Important access to all AUA guidelines
- 12.••Institute of Medicine. Clinical Practice Guidelines we can Trust. 2011. Good description on how to create and develop meaningful guidelines Google Scholar
- 13.Donabedian A. Explorations in Quality Assessment and Monitoring Vol. 1. The Definition of Quality and Approaches to its Assessment. Ann Arbor, MI: Health Administration Press; 1980.Google Scholar
- 15.••Democratic Policy Committee. The Patient Protection and Affordable Care Act; Cost Containment. 2010. Very good summary on the Affordable Care Act Google Scholar
- 16.Centers for Medicaire and Medicaid Services. 2013 Physician Quality Reporting System (PQRS): Implementation Guide -- Claims-based Reporting for Incentinve. 2013.Google Scholar
- 17.••Centers for Medicaire and Medicaid Services. 2012 Physician Quality Reporting System (Physician Quality Reporting) Measures List. 2012. Important list of the measures used for the physician quality reporting sytstem Google Scholar
- 21.Palfrey JS. Child Health in America; Making a Difference Through Advocacy. Baltimore, MD: The Johns Hopkins University Press; 2006.Google Scholar
- 22.Grumbach K, Grundy P. Outcomes of Implementing Patient Centered Medical Home Interventions: A Review of the Evidence from Prospective Evaluation Studies in the United States. 2010Google Scholar
- 24.Eunice Kennedy Shriver National Institute of Child Health and Human Development. Progress on Pelvic Floor Disorders (PFDs); Research and Collaborative Efforts of Scientists, Clinicians, and Patients Result in Advances. 2013. http://www.nichd.nih.gov/news/resources/spotlight/Pages/051313-PFD.aspx. Accessed June 17, 2013.
- 25.American Urogynecologic Society (AUGS). Building a national PFD registry. July 19, 2012. http://www.augs.org/p/bl/et/blogid=6?blogaid=59.
- 26.FDA. Public Health Notificatoin: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence. 2008;http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm061976.htm.
- 27.FDA. Safety Communication: UPDATE on Serious Complications Associated wtih Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse. 2011;http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm.
- 28.U.S. Food and Drug Administration. Urogynecologic Surgical Mesh Implants; FDA's Role and Activities. 2013. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/ucm262301.htm. Accessed June 17, 2013.